| 1 |
Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer[J]. Lancet, 2014, 384(9951):1376-1388.
|
| 2 |
Mizutani Y, Nakanishi H, Li YN, et al. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis[J]. Int J Oncol, 2007, 30(4):919-925.
|
| 3 |
Desplanques G, Giuliani N, Delsignore R, et al. Impact of XIAP protein levels on the survival of myeloma cells[J]. Haematologica, 2009, 94(1):87-93.
|
| 4 |
Zhang Y, Zhu J, Tang Y, et al. X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma[J]. Diagn Pathol, 2011, 6:49.
|
| 5 |
Castells M, Milhas D, Gandy C, et al. Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation[J]. Cell Death Dis, 2013, 4:e887.
|
| 6 |
Mansouri A, Zhang Q, Ridgway LD, et al. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation[J]. Oncol Res, 2003, 13(6-10):399-404.
|
| 7 |
Schimmer AD, Dalili S, Batey RA, et al. Targeting XIAP for the treatment of malignancy[J]. Cell Death Differentiat, 2006, 13(2):179-188.
|
| 8 |
关芳灵，马敏，尚丽芳，等．X-连锁凋亡抑制蛋白在胆脂瘤中的表达及其与细胞凋亡的关系[J]．山西医药杂志，2008，37(6)：493-494.
|
| 9 |
Wang Y, Mao H, Hao Q, et al. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer[J]. Regul Pept, 2012, 178(1-3):36-42.
|
| 10 |
Zhao WJ, Deng BY, Wang XM, et al. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells[J]. Asian Pac J Cancer Prev, 2015, 16(6):2453-2458.
|
| 11 |
兰永连，任国庆，贾婵维，等．p53依赖的X-连锁凋亡抑制蛋白调节与卵巢癌顺铂耐药的关系[J]．中国优生与遗传杂志，2009，17(3)：17-19.
|
| 12 |
Sapi E, Alvero AB, Chen W, et al. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol[J]. Oncol Res, 2004, 14(11-12):567-578.
|
| 13 |
张虹，谢潇潇．X连锁凋亡抑制蛋白cDNA转染与卵巢癌细胞顺铂耐药性[J]．国际妇产科学杂志，2009，36(4)：336-337.
|
| 14 |
Shaw TJ, Lacasse EC, Durkin JP, et al. Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo[J]. Int J Cancer, 2008, 122(6):1430-1434.
|
| 15 |
Kluger HM, McCarthy MM, Alvero AB, et al. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization[J]. J Transl Med, 2007, 5:6.
|
| 16 |
张红梅，张敬川．U0126对MCF-7细胞株化疗敏感性及XIAP蛋白表达的影响[J]．临床肿瘤学杂志，2008，13(6)：503-507.
|
| 17 |
Yano K, Horinaka M, Yoshida T, et al. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells[J]. Int J Oncol, 2011, 38(2):365-374.
|
| 18 |
陈为，彭萍．X染色体连锁的凋亡抑制蛋白和Caspase-3在上皮性卵巢癌中的表达及其临床意义[J]．细胞与分子免疫学杂志，2010，26(7)：673-674，678.
|
| 19 |
Wu M, Yuan S, Szporn AH, et al. Immunocytochemical detection of XIAP in body cavity effusions and washes[J]. Mod Pathol, 2005, 18(12):1618-1622.
|
| 20 |
Wang JH, Nao JF, Zhang M, et al. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways[J]. Tumour Biol, 2014, 35(12):11985-11994.
|
| 21 |
Bao W, Zhu F, Duan Y, et al. HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP[J]. Biomed Pharmacother, 2015, 70:97-102.
|
| 22 |
He X, Khurana A, Maguire JL, et al. HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation[J]. Int J Cancer, 2012, 130(5):1029-1035.
|
| 23 |
Miyamoto M, Takano M, Iwaya K, et al. X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary[J]. Br J Cancer, 2014, 110(12):2881-2886.
|
| 24 |
Ma JJ, Chen BL, Xin XY. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma[J]. Eur J Obstet Gynecol Reprod Biol, 2009, 146(2):222-226.
|
| 25 |
Zhang X, Huang L, Zhao Y, et al. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly[J]. Acta Biochim Biophys Sin (Shanghai), 2013, 45(12):995-1001.
|
| 26 |
Pang Y, Mao H, Shen L, et al. MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP[J]. Onco Targets Ther, 2014, 7:587-597.
|